SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-17-005989
Filing Date
2017-02-06
Accepted
2017-02-03 17:38:30
Documents
1
Group Members
DR. ANAND MEHRA (MEHRA)DR. JAMES I. HEALY (HEALY)DR. MICHAEL F. POWELL (POWELL)SOFINNOVA MANAGEMENT VIII, L.L.C. (SM VIII)

Document Format Files

Seq Description Document Type Size
1 SC 13D v458384_sc13d.htm SC 13D 101111
  Complete submission text file 0001144204-17-005989.txt   102757
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners VIII, L.P. (Filed by) CIK: 0001524064 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228
Business Address CHEMIN DES AULX, 12 PLAN-LES-OUATES V8 1228 0041-0-22-552-1558
ObsEva SA (Subject) CIK: 0001685316 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89794 | Film No.: 17573306
SIC: 2834 Pharmaceutical Preparations